期刊文献+

LAMA3基因突变致laryngo-onycho-cutaneous综合征1例

Laryngo-onycho-cutaneous syndrome caused by variant of LAMA3:a case report
原文传递
导出
摘要 本文报道1例发生于女性儿童的laryngo-onycho-cutaneous综合征(LOCS)。患儿女,4岁,因“出生后反复声音嘶哑、喉鸣音4年余,加重2个月”于2020年10月27日在上海交通大学医学院附属上海儿童医学中心耳鼻咽喉科就诊。体格检查示全身散在皮疹及溃疡样皮肤缺损,双侧脚趾甲及双手指甲部分缺如,牙釉质发育不良及牙齿异常等表现。电子喉镜检查发现声门上区肉芽组织增生明显,声门下狭窄,双侧声带活动受限。基因检测结果提示患儿LAMA3基因存在复合杂合变异c.151dupG(p.Val51Glyfs*4)和c.3216G>A(p.Ser1072Ser),其父母分别各携带LAMA3基因的一处杂合变异。结合患儿的临床表型、电子喉镜表现以及全外显子组检测结果,该患儿被诊断为LOCS。因父母拒绝进一步治疗,未给予干预措施,密切随访中。
作者 李俊阳 林一杭 李牛 王剑 李幼瑾 Li Junyang;Lin Yihang;Li Niu;Wang Jian;Li Youjin(Department of Otorhinolaryngology,Shanghai Children′s Medical Center,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China;Department of Medical Genetics and Molecular Diagnostic Laboratory,Shanghai Children′s Medical Center,School of Medicine,Shanghai Jiao Tong University,Shanghai 200127,China)
出处 《中华耳鼻咽喉头颈外科杂志》 CSCD 北大核心 2022年第2期207-209,共3页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 国家自然科学基金(82071015)。
  • 相关文献

参考文献1

二级参考文献16

  • 1Abu Sa'd J, Indelman M, Pfendner E, et al. Molecular epidemiology of hereditary epidermolysis bullosa in a Middle Eastern population. J Invest Dermatol, 2006, 126(4):777-781.
  • 2Robbins PB, Lin Q, Goodnough JB, et al. In vivo restoration of laminin 5 beta 3 expression and function in junctional epidermolysis bullosa. Proc Natl Acad Sci U S A, 2001, 98 (9): 5193-5198.
  • 3Ortiz-Urda S, Lin Q, Yant SR, et al. Sustainable correction of junctional epidermolysis bullosa via transposon-mediated nonviral gene transfer. Gene Ther, 2003, 10( 13): 1099-1104.
  • 4Di Nunzio F, Maruggi G, Ferrari S, et al. Correction of laminin-5 deficiency in human epidermal stem cells by tran- scriptionally targeted lentiviral vectors. Mol Ther, 2008, 16 (12): 1977-1985.
  • 5Poturreyron C, Cox G, Mao X, et al. Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J Invest Dermatol, 2007, 127( 10): 2438-2444.
  • 6Chen M, O'Toole EA, Muellenhoff M, et al. Development and characterization of a recombinant truncated type VII collagen "minigene". Implication for gene therapy of dystrophic epidermolysis bullosa. J Biol Chem, 2000, 275(32): 24429-24435.
  • 7Chen M, Kasahara N, Keene DR, et al. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat Genet, 2002, 32(4): 670-675.
  • 8Ortiz-Urda S, Lin Q, Green CL, et al. Injection of genetically engineered fibroblasts corrects regenerated human epidermolysis bullosa skin tissue. J Clin Invest, 2003, 111 (2): 251-255.
  • 9Woodley DT, Keene DR, Atha T, et al. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullOsa skin tissue in vivo. Mol Ther, 2004, 10 (2): 318-326.
  • 10Goto M, Sawamura D, Ito K, et al. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa. J Invest Dermatol, 2006, 126 (4): 766-772.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部